WALTHAM, Mass.--(BUSINESS WIRE)--June 13, 2006--NeuroMetrix, Inc. (NASDAQ: NURO - News), a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies, announced today that it is scheduled to present at Needham’s Fifth Annual Biotechnology and Medical Conference at the New York Palace Hotel in New York City at 3:30pm (EST) on Thursday, June 15th. The audio presentation will be simultaneously available via webcast on the “Investors” home page at http://www.neurometrix.com.
